Abstract
Aim:
Overexpression of human tissue kallikrein (HK), mediated by recombinant adeno-associated virus (rAAV), decreased blood pressure in spontaneous hypertensive rats (SHRs) and reduced injury to the heart, aorta and kidney. In this study, we used both an in vivo animal model and in vitro cell culture system to investigate whether rAAV-mediated HK gene therapy protects against organ damage by inhibiting cell apoptosis.
Methods:
rAAV encoding HK (rAAV-HK) or LacZ (rAAV-lacZ) were delivered as a control to spontaneously hypertensive rats (SHRs) and cultured human embryonic kidney (HEK) 293 cells.
Results:
Treatment with rAAV-HK decreased cell apoptosis in the target organs of SHRs and also inhibited lipopolysaccharide (LPS)-induced HEK 293 apoptosis. The rAAV-HK delivery system also increased the levels of apoptosis-inhibiting proteins bcl-2 and bcl-xL, and decreased the level of Bax and the activity of caspase 3, two promoters of apoptosis. In addition to its role in the inhibition of apoptosis, rAAV-HK also activated the cell survival and proliferation signaling pathways ERK1/2 and PI3K/AKT.
Conclusion:
rAAV-mediated HK gene delivery has multiple therapeutic possibilities for treating hypertension, not only by decreasing blood pressure, but also by directly inhibiting end-organ damage.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–52.
Phillips MI . Gene therapy for hypertension: the preclinical data. Hypertension 2001; 38 (Part 2): 543–8.
Monahan PE, Samulski RJ . AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24–30.
Mueller C, Flotte TR . Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 2008; 15: 858–63.
Chao J, Chao L . Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 2005; 90: 291–8.
Wang T, Li H, Zhao C, Chen C, Li J, Chao J, et al. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Ther 2004; 11: 1342–50.
Wang T, Hou L, Liu Z, Wang Y, Chen C, Xiao X, et al. Intramuscular delivery of raav-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats. Acta Pharmacol Sin 2007; 28: 1898–1906.
Yan J, Wang T, Li J, Xiao X, Wang D . Recombinant adeno-associated virus-mediated human kallikrein gene therapy prevents high-salt diet-induced hypertension without effect on basal blood pressure. Acta Pharmacol Sin 2008; 29: 808–14.
Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224–32.
Kramarenko II, Bunni MA, Morinelli TA, Raymond JR, Garnovskaya MN . Identification of functional bradykinin B2 receptors endogenously expressed in HEK293 cells. Biochem Pharmacol 2009; 77: 269–76.
Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642–8.
Gonzalez A, Fortuno MA, Querejeta R, Ravassa S, Lopez B, Lopez N, et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 2003; 59: 549–62.
Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859–70.
Diep QN, El Mabrouk M, Yue P, Schiffrin EL . Effect of at1 receptor blockade on cardiac apoptosis in angiotensin ii-induced hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H1635–41.
Gonzalez A, Lopez B, Ravassa S, Querejeta R, Larman M, Diez J, et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39: 75–80.
Messadi-Laribi E, Griol-Charhbili V, Pizard A, Vincent MP, Heudes D, Meneton P, et al. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia. J Pharmacol Exp Ther 2007; 323: 210–6.
Westermann D, Schultheiss HP, Tschöpe C . New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration. Int Immunopharmacol 2008; 8: 148–54.
Yin H, Chao L, Chao J . Kallikrein/Kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad{middle dot}14-3-3 signaling pathways. J Biol Chem 2005; 280: 8022–30.
Messadi-Laribi E, Griol-Charhbili V, Gaies E, Vincent MP, Heudes D, Meneton P, et al. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice. Clin Exp Pharmacol Physiol 2008; 35: 489–93.
Chao J, Bledsoe G, Yin H, Chao L . The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol Chem 2006; 387: 665–75.
Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, et al. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Neprol Dial Transplant 2006; 21: 624–33.
Tu L, Xu X, Wan H, Zhou C, Deng J, Xu G, et al. Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats. Hum Gene Ther 2008; 19: 318–30.
Intengan HD, Schiffrin EL . Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38: 581–7.
Irani K . Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87: 179–83.
Pollman MJ, Yamada T, Horiuchi M, Gibbons GH . Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79: 748–56.
Yamada T, Horiuchi M, Dzau VJ . Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996; 93: 156–60.
Cattaruzza M, Dimigen C, Ehrenreich H, Hecker M . Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J 2000; 14: 991–8.
Jeong SY, Seol DW . The role of mitochondria in apoptosis. BMB Rep 2008; 41: 11–22.
Li J, Yuan J . Caspases in apoptosis and beyond. Oncogene 2008; 27: 6194–206.
Acknowledgements
This work was supported in part by funds from the National “863” Plan Project (No 2006AA02A406), the National Natural Science Foundation of China (No 30800458), and the National Basic Research Program of China 973 Program (2007CB512004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yan, Jt., Wang, T. & Wang, Dw. Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis. Acta Pharmacol Sin 30, 1253–1261 (2009). https://doi.org/10.1038/aps.2009.114
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.114
